Insider · CIK 0002082864
Thomas Clay Kahler
Files at CNTN (Tharimmune, Inc.). First filing -, latest -.
In brief
Thomas Clay Kahler files SEC Form 4 as director at CNTN (Tharimmune, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Thomas Clay Kahler has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 3, 2025 | CNTN Tharimmune, Inc. | AGrant or award Stock Optionderivative | +17,500 | $0.00 | $0 | 67,500 | Nov 5, 2025 |
Questions about Thomas Clay Kahler
Answered from the filings on this page, as of the latest one.
Is Thomas Clay Kahler buying or selling?
Thomas Clay Kahler has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Thomas Clay Kahler's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas Clay Kahler has 0.
Where does Thomas Clay Kahler file Form 4?
Thomas Clay Kahler has filed Form 4 at CNTN (Tharimmune, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.